CClinicalTrials.gg
TerminatedNCT01922635LYMPHOQOLUpdated May 18, 2023

Validation of Metrological Properties of Lymphoqol

An interventional study of Valadation of the metrological properties of questionnaire of quality of life in Primary Lymhedema, sponsored by University Hospital, Montpellier. Terminated at 1 site in France. Open to participants aged 6 Years to 25 Years. Per ClinicalTrials.gov, last updated 2023-05-18.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Supportive care

Why this study was terminated
Modification the study with a new questionnaire was not successful.
Phase
Not applicable
Study type
Interventional
Enrollment
37
Allocation
Not applicable
Ages
6 Years to 25 Years
Sex
All
01

Study summary

The constitutional lymphœdema is a rare disease with an annual incidence before the age of 20 years considered at 1,15/100 000. This chronic, incurable disease without hiring directly the prognosis for survival, alter the body image imposing a "visible" deformity and of which the treatment which aims at reducing and at stabilizing the physical deformation is binding and expensive. The lymphœdema is a crippling disease of the child. As such, it rings on the everyday life of the child and on the family environment. This question is all the more important, that all the studies show that the success of the treatment bases on the compliance in the concentration and in the care of hygiene. The parameters of the success of these treatments at the child are not known.

Read the detailed description

In the literature we find no specific information on the psychic and social repercussions of the lymphœdema for the child who is affected. If the psychic and social repercussions of the secondary lymphœdema in the breast cancer are well known, very few things are it on those of the primary lymphœdema. Some studies estimate globally the quality of life of the patients with a lymphœdema whatever is the origin and the etiologie. These studies of money groups suggest that the psychic difficulties and of therapeutic care are not identical. A single study approaches the specific question of the lymphœdema of the child by focusing on the real-life experience of expanding child of a primary lymphœdema.The construction and the validation of a tool measuring the quality of life of the children and the young adults affected by lymphœdema congenital appears as a starting point. A tool which would first of all allow to make the current situation for the regional level, and then can envisage national actions common. According to recent studies, the evolution of the lymphoedema is different according to the forms of initial clinical expression of the lymphoedema, we wish we can thus know during this study the impact of these various clinical forms on the quality of life of the patients. A genetic collection will be realized for that purpose (genetic research).

02

Conditions studied

  • Primary Lymhedema

Keywords

  • Primary lymphedema quality of life, genetic research
03

In context

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Primary lymphedema, stage 2 or 3 ISL

Exclusion criteria

Exclusion Criteria:

  • Primary lymphedema stage 1, secondary lymphedema, Minimum 6 years, maximum 25
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
37 participants (actual)

Study arms

  • Other
    1

    Other: Valadation of the metrological properties of questionnaire of quality of life

Interventions

  • OtherValadation of the metrological properties of questionnaire of quality of life
06

What researchers measure

Primary outcomes

  1. Validation of the metrological properties of questionnaire of quality of life LYMPHOQOL

    Time frame: 3 Years

07

Study locations

1 site
  • CHU Montpellier
    Montpellier, Herault 34295, France
08

References and documents

Publications

  • Quere I, Stasi E, Mestre S, Roessler J, Roccatello D, Moffatt C. International Camps for Children with Lymphedema and Lymphatic Anomalies: When Education Links with Psychosocial Research. Lymphat Res Biol. 2021 Feb;19(1):36-40. doi: 10.1089/lrb.2020.0095. PubMed 33625888 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01922635
Lead sponsor
University Hospital, Montpellier
Collaborators
University Hospital, Marseille
Responsible party
Sponsor
First posted
Aug 14, 2013
Start date
Jul 2013
Primary completion
Jan 13, 2022
Completion
Jan 13, 2022
Last update
May 18, 2023

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion